πŸ‡ΊπŸ‡Έ FDA
Patent

US 8722662

Heterocyclic compounds

granted A61PA61P13/00A61P13/06

Quick answer

US patent 8722662 (Heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P13/00, A61P13/06, A61P15/12, A61P25/00